HCID 67036089, compound → HCID 178519147, compound
Reaction equation
[Cl:1][C:2]1[CH:3]=[C:4]([C@H:9]2[CH2:13][O:12][C:11](=[O:14])[N:10]2[C:15]2[CH:20]=[CH:19][N:18]3[N:21]=[CH:22][C:23]([C:24]4[CH:29]=[CH:28][C:27]([C:30]5[N:34]=[CH:33][N:32](COCC[Si](C)(C)C)[N:31]=5)=[C:26]([F:43])[CH:25]=4)=[C:17]3[N:16]=2)[CH:5]=[CH:6][C:7]=1[F:8].ClC1C=C([C@H]2COC(=O)N2C2C=CN3N=CC(C4C=CC(C5N(COCC[Si](C)(C)C)N=CN=5)=C(F)C=4)=C3N=2)C=CC=1F>>[Cl:1][C:2]1[CH:3]=[C:4]([C@H:9]2[CH2:13][O:12][C:11](=[O:14])[N:10]2[C:15]2[CH:20]=[CH:19][N:18]3[N:21]=[CH:22][C:23]([C:24]4[CH:29]=[CH:28][C:27]([C:30]5[N:34]=[CH:33][NH:32][N:31]=5)=[C:26]([F:43])[CH:25]=4)=[C:17]3[N:16]=2)[CH:5]=[CH:6][C:7]=1[F:8]Participants
3
Procedure
(S)-4-(3-chloro-4-fluorophenyl)-3-(3-(3-fluoro-4-(1H-1,2,4-triazol-3-yl)phenyl)pyrazolo[1,5-a]pyrimidin-5-yl)oxazolidin-2-one (19 mg, 77%) was prepared by the procedure described in Example 1, Step 9, using a mixture of (S)-4-(3-chloro-4-fluorophenyl)-3-(3-(3-fluoro-4-(1-((2-(trimethylsilyl)ethoxy)methyl)-1H-1,2,4-triazol-3-yl)phenyl)pyrazolo[1,5-a]pyrimidin-5-yl)oxazolidin-2-one and (S)-4-(3-chloro-4-fluorophenyl)-3-(3-(3-fluoro-4-(1-((2-(trimethylsilyl)ethoxy)methyl)-1H-1,2,4-triazol-5-yl)phenyl)pyrazolo[1,5-a]pyrimidin-5-yl)oxazolidin-2-one. LCMS (APCI+) m/z 495, 497 [M+H]+.
Sources & evidence
- ORD record
- ord-2aeb989e01504e0abc9c6aabd720940b
- Source dataset
- uspto-grants-2014_10
- Patent number
- US08865726B2
Reaction notes
Loading…